Home › Funds › Mirova US LLC › BSX

Mirova US LLC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Mirova US LLC reported holding 2,903,632 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$126.7M, representing 1.38% of its reported portfolio and ranking #30 among its reported holdings. Mirova US LLC has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)2.90M sh
Reported value held$126.74M
Portfolio Weight1.38%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Mirova US LLC's BSX position evolved

Mirova US LLC first disclosed a stake in BSX in Q4 2025 at 1,370,029 shares (US$130.6M). The position peaked in Q1 2026 at 2,203,401 shares, worth US$138.3M. Across 4 filings, Mirova US LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,903,632 shares valued at US$126.7M — a reduction of -197,846 shares quarter over quarter.. Notable position changes include a 61% increase in Q1 2026 (shares fell 32% over the following quarter), a 41% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.37M $130.63M New
Q1 2026 2.20M $138.26M Add
Q2 2026 3.10M $132.37M Add
Q3 2026 2.90M $126.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Mirova US LLC held BSX?

Mirova US LLC has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Mirova US LLC's current position in BSX?

As of Q3 2026, Mirova US LLC holds 2.90M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $126.74M, representing 1.38% of its reported portfolio and ranking #30.

Has Mirova US LLC been buying or selling BSX?

In the latest 13F filing (Q3 2026), Mirova US LLC reduced its position in BSX. The position peaked in Q1 2026 at 2.20M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.